Intravitreal injections (IVI) have become the most common intraocular procedure worldwide
with increasing numbers every year. The article presents the most up-to-date review on IVI …

The treatment of ocular neovascular diseases is being revolutionized by intravitreal
therapies targeting vascular endothelial growth factor (VEGF). Two agents are approved for …

Purpose: To review evidence and provide updated guidelines on intravitreal (IVT) injection
technique and monitoring. Methods: A review of the published literature on IVT injection from …

Background: Intravitreal ranibizumab and pegaptanib are registered for neovascular age-
related macular degeneration. No formal safety study has been conducted for intravitreal …

Purpose: To determine the cumulative incidence and annual incidence of intraocular
hemorrhage (subretinal hemorrhage or vitreous hemorrhage) in patients with neovascular …

Purpose: To report the incidence of traumatic lens injuries as a complication of intravitreal
injection at 5 high-volume academic centers. Methods: We determined in a retrospective …

Diabetic retinopathy remains a leading cause of visual loss worldwide. Patients with
diabetes mellitus commonly have multiple comorbidities treated with a wide variety of …

PURPOSE: To evaluate the incidence of and risk factors for subretinal hemorrhages in age-
related macular degeneration (AMD) patients on anticoagulation or antiplatelet therapy …

Purpose: To evaluate the effect of concomitant systemic therapy in patients with choroidal
neovascularization secondary to age-related macular degeneration (AMD) treated by …

Purpose: To assess the risk of hemorrhagic complications when performing intravitreal
injections on systemically anticoagulated patients. Methods: A single-center retrospective …